OFF-LABEL PROMOTIONS SHOULD CONTINUE TO RECEIVE CASE-BY-CASE CONSIDERATION, FDLI COUNSEL BURDITT SUGGESTS; FDA REFORM COULD SHIFT TO INCREMENTAL STRATEGY
Executive Summary
FDA's regulation of off-label promotions will continue to be an ad hoc process, Burditt & Radzius (Chicago) attorney George Burditt suggested at a Washington Legal Foundation meeting Nov. 19 in Washington, D.C.